跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avastin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avastin
Approved
STANDARD
Avastin
F. Hoffmann-La Roche, Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a3164ad178875c16
Company
F. Hoffmann-La Roche, Ltd.
Type
Standard
Approval Details
Approval Id
a3164ad178875c16
Drug Approval Philippines Name
Avastin
Product Name
Avastin
Registration Number
BR-969
Brand Name
Avastin
Generic Name
Bevacizumab
Dosage Form
Concentrate for Solution for Infusion (IV)
Dosage Strength
400 mg/16 mL (25mg/mL)
Manufacturer
F. Hoffmann-La Roche, Ltd.
Trader
Switzerland
Distributor
Roche (Philippines), Inc.
Company Detail Path
/organization/f-hoffmann-la-roche-ltd-switzerland
Issuance Date
24 March 2023
Expiry Date
24 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a3164ad178875c16
Type
Standard
Back to Philippines FDA Approvals